{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:53:24Z","timestamp":1794959604044,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1016\/s0002-9343(00)00567-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T06:44:40Z","timestamp":1027579480000},"page":"556-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance"],"prefix":"10.1016","volume":"109","author":[{"given":"Cristiana","family":"Catena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Zingaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Casaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo A","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9343(00)00567-2_BIB1","first-page":"7","article-title":"Report on the management of renal failure in Europe, XXII, 1991","volume":"3","author":"Rainer","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJM197403282901301","article-title":"Accelerated atherosclerosis in prolonged maintenance hemodialysis","volume":"290","author":"Lindner","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ki.1981.62","article-title":"Lipid abnormalities in uremia, dialysis and transplantation","volume":"19","author":"Chan","year":"1981","journal-title":"Kidney Int"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB4","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/ki.1997.233","article-title":"Atherosclerosis and arteriosclerosis in chronic renal failure","volume":"51","author":"London","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0272-6386(96)90523-5","article-title":"Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipids as cardiovascular risk factors in chronic hemodialysis, and continuous ambulatory peritoneal dialysis patients","volume":"27","author":"Tomura","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/clinchem\/39.4.559","article-title":"Prothrombin activation fragment assay","volume":"39","author":"Rosenberg","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0609.1992.tb00567.x","article-title":"Detection of prethrombotic state due to procoagulant imbalance","volume":"48","author":"Mannucci","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI108902","article-title":"Generation of the combined prothrombin activation peptide (F1,2) during the clotting of blood and plasma","volume":"60","author":"Aronson","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2007-1005042","article-title":"Detection and relevance of cross linked fibrin derivatives in blood","volume":"8","author":"Graeff","year":"1982","journal-title":"Semin Thromb Haemost"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1681\/ASN.V871147","article-title":"Long-term effects of erythropoietin therapy on fistula stenosis, and plasma concentrations of PDGF, and MCP-1 in hemodialysis patients","volume":"8","author":"De Marchi","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-3848(96)00145-4","article-title":"Hemostasis, platelet function and serotonin in acute and chronic renal failure","volume":"83","author":"Malyszko","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB12","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/oxfordjournals.ndt.a027140","article-title":"The effects of gemfibrozil upon the hypercoagulable state in dyslipidaemic patients with chronic renal failure","volume":"11","author":"Irish","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0049-3848(91)90207-D","article-title":"Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment","volume":"64","author":"Tomura","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0272-6386(12)80136-3","article-title":"Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease","volume":"23","author":"Vaziri","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","article-title":"Fibrinogen and risk of cardiovascular disease","volume":"258","author":"Kannel","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9150(97)00273-6","article-title":"Cardiovascular disease, fibrinogen and the acute phase response","volume":"137","author":"Irish","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB17","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1093\/ndt\/12.12.2597","article-title":"Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients","volume":"12","author":"Jungers","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.7326\/0003-4819-129-6-199809150-00006","article-title":"Increased serum lipoprotein(a) levels in patients with early renal failure","volume":"129","author":"Sechi","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/bmj.293.6547.611","article-title":"Recommendations on blood pressure measurement","volume":"293","author":"Petrie","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB20","doi-asserted-by":"crossref","unstructured":"The Guidelines Subcommittee of the WHO\/ISH Mild Hypertension Liaison Committee. 1993 Guidelines for the management of mild hypertension. Memorandum from a World Health Organization\/International Society of Hypertension Meeting. Hypertension. 1993;22:392\u2013403.","DOI":"10.1161\/01.HYP.22.3.392"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0026-0495(92)90019-7","article-title":"Insulin hypersecretion","volume":"11","author":"Sechi","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB22","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.1997.03540450045033","article-title":"Association of lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension","volume":"277","author":"Sechi","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0049-3848(88)90029-1","article-title":"Method for determination of functional (clottable) fibrinogen by the new family of ACL coagulometers","volume":"52","author":"Rossi","year":"1988","journal-title":"Thromb Res"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0049-3848(83)90108-1","article-title":"An immunoassay for human D-dimer using monoclonal antibodies","volume":"31","author":"Rylatt","year":"1983","journal-title":"Thromb Res"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0038-1647475","article-title":"Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide","volume":"65","author":"Pelzer","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB26","unstructured":"USRDS Annual Report. Am J Kidney Dis. 1994;24(suppl 2):S88\u2013S95."},{"key":"10.1016\/S0002-9343(00)00567-2_BIB27","first-page":"522","article-title":"Plasma D-dimer","volume":"61","author":"Gordge","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB28","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00007611-199309000-00009","article-title":"Detection of fibrin D-dimer in plasma and urine of pregnant women using dimertest latex assay","volume":"86","author":"Trofatter","year":"1993","journal-title":"South Med J"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB29","doi-asserted-by":"crossref","unstructured":"Shibata T, Magari Y, Kamberi P, et al. Significance of fibrin\/fibrinogen degradation products (FDP) D-dimer measure by a highly sensitive ELISA method with a new monoclonal antibody (D-D Eqn. 72) in various renal diseases. Clin Nephrol. 1995;44:91\u201395.","DOI":"10.1159\/000188973"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF02827247","article-title":"Increased thrombin generation in patients with chronic renal failure","volume":"27","author":"Sagripanti","year":"1997","journal-title":"Int J Clin Lab Res"},{"issue":"suppl A","key":"10.1016\/S0002-9343(00)00567-2_BIB31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/eurheartj\/16.suppl_A.21","article-title":"Epidemiology of fibrinogen","volume":"16","author":"Folsom","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","article-title":"Haemostatic function and ischemic heart disease","volume":"2","author":"Meade","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB33","first-page":"565","article-title":"Plasma fibrinogen\u2014a major coronary risk factor","volume":"35","author":"Stone","year":"1985","journal-title":"J R Coll Gen Pract"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198408233110804","article-title":"Fibrinogen as a risk factor for stroke and myocardial infarction","volume":"311","author":"Wilhelmsen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ije\/20.2.384","article-title":"Edinburgh Artery Study","volume":"20","author":"Fowkes","year":"1991","journal-title":"Int Epidemiol"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0002-9343(89)80616-3","article-title":"The normal and morbid biology of fibrinogen","volume":"87","author":"Dang","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00041433-199312000-00008","article-title":"Fibrinogen and atherothrombogenesis","volume":"4","author":"Koenig","year":"1993","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.ATV.12.7.780","article-title":"Determinants of plasma fibrinogen","volume":"12","author":"Krobot","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0021-9150(91)90167-2","article-title":"Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors","volume":"91","author":"Folsom","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0049-3848(90)90071-J","article-title":"The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit","volume":"57","author":"Mitropulos","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/S0002-9343(00)00567-2_BIB41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1172\/JCI110069","article-title":"Effect of fibrinogenolytic products D and E on fibrinogen and albumin synthesis in the rat","volume":"67","author":"Franks","year":"1981","journal-title":"J Clin Invest"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934300005672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934300005672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:30:04Z","timestamp":1757575804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934300005672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S0002934300005672"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9343(00)00567-2","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9343(00)00567-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}